It was the first of eight contracts between the government and the company that generally take two forms. In one type of contract, Kite licenses patented inventions and agrees to pay the government royalties, roughly 5 percent of sales of any commercial product arising from a particular patent. However, there is no such license specifically for   because the underlying treatment was not patented by the N. C. I. so royalties will be minimal. 